Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Daniel Philip Nussbaum
Assistant Professor of Surgery
Surgical Oncology
daniel.nussbaum@duke.edu
DUMC 2612, Durham, NC 27710
DUMC 2612, Durham, NC 27710
Research
More About This Person
glance {hide_children: true, active: false, enabled: true}
At a Glance
credentials {hide_children: true, active: false, enabled: true}
Credentials
Education
Training & Certifications
academic-experience {hide_children: true, active: false, enabled: true}
Academic Experience
Current Appointments & Affiliations
Previous Appointments & Affiliations
expertise {hide_children: true, active: false, enabled: false}
Expertise
research {hide_children: false, active: true, enabled: true}
Research
Selected Grants
publications {hide_children: true, active: false, enabled: true}
Publications
Selected Publications
artistic-works {hide_children: true, active: false, enabled: false}
Artistic Works / Events
teaching {hide_children: true, active: false, enabled: false}
Teaching
advising-mentoring {hide_children: true, active: false, enabled: false}
Advising & Mentoring
recognition {hide_children: true, active: false, enabled: false}
Recognition
professional-activities {hide_children: true, active: false, enabled: false}
Professional Activities
Manage Profile
Embed Profile Data
Manage Profile
Embed Profile Data
Selected Grants
A Phase II, Open-Label, Multicenter, Randomized Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFolfirinox versus mFolfirinox alone in Patients with Resected Pancreatic Ductal Adenocarcinoma Protocol G044479
Clinical Trial
Principal Investigator ·
Awarded by Genentech, Inc. ·
2023 - 2033
Advanced Immunobiology Traning Program for Surgeons
Inst. Training Prgm or CME
Mentor ·
Awarded by National Institutes of Health ·
2019 - 2029
Single Cell and Spatial Analysis of Lethal Breast Cancers
Research
Co Investigator ·
Awarded by Department of Defense ·
2024 - 2028
A Window-of-Opportunity Trial Using Neoadjuvant Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer
Research
Co-Principal Investigator ·
Awarded by Marc Lustgarten Pancreatic Cancer Foundation ·
2023 - 2026
THE INNOVATIONS PANCREATIC CANCER RESEARCH GRANT
Research
Mentor ·
Awarded by Project Purple ·
2024 - 2025
Comprehensive Profiling of Hepatic Immune Populations to Target Occult Liver Metastasis in Pancreatic Cancer
Research
Principal Investigator ·
Awarded by Hopper-Belmont Foundation ·
2023 - 2024
The DCN Passport: A Novel, Patient-Centered Approach to Improve Care for Gastric/Gastroesophageal Junction Cancer Across an Academic-Community Oncology Network
Clinical Trial
Co Investigator ·
Awarded by Eli Lilly and Company ·
2020 - 2023
A Platform for Real-time Drug Profiling of Patient-Derived Melanomas
Fellowship
PD/PI ·
Awarded by National Institutes of Health ·
2014 - 2016
